Time to Achieving Clinically Significant Outcomes After Meniscal Allograft Transplantation

Mostrar otras versiones (1)

PURPOSE: To determine the time to achieving minimal clinically important difference (MCID) and patient acceptable symptomatic state (PASS) for commonly administered patient-reported outcome (PRO) measures and risk factors affecting achievement of clinically significant outcomes in patients undergoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Huddleston, Hailey P., Polce, Evan M., Gilat, Ron, Mehta, Nabil, Alzein, Mohamad, Dandu, Navya, Parvaresh, Kevin C., Cole, Brian J., Yanke, Adam B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Clinical Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310214/
https://www.ncbi.nlm.nih.gov/pubmed/35864782
http://dx.doi.org/10.1177/19476035221102568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310214/
https://www.ncbi.nlm.nih.gov/pubmed/35864782
http://dx.doi.org/10.1177/19476035221102568

Ejemplares similares